1.Rapid versus gradual external ventricular drain weaning: a general review of best practices
Zachary I. MERHAVY ; Wyatt FERRELLE ; Bhavyata VADDAVALLI ; Samir RUXMOHAN
Journal of Neurocritical Care 2024;17(1):1-6
Rapid versus gradual external ventricular drain (EVD) weaning methods have been widely debated, aiming to establish a standard clinical practice. The techniques used in each approach offer their own set of benefits and associated risks. Many published works continue to deliberate and dispute each other on the topic, as many believe gradual weaning is preferable due to its perceived potential to decrease ventriculoperitoneal shunt (VPS) dependency. In contrast, rapid weaning is known to have benefits such as a reduction in ventriculostomy-associated infections. Additionally, both weaning methods have been further debated due to the perception of the risks associated, which for gradual weaning includes a longer hospital stay. This literature review explores both sides of this debate, providing pros and cons to each weaning method to better unify the disconnect within the field. Based on the current research available, it is clear that due to a lengthy and more consistent list of benefits as well as overall decreased associated risks, rapid weaning is the superior form of EVD treatment method and should become the standard for clinical practice when performing EVDs on patients suffering from aneurysmal subarachnoid hemorrhages.
2.Granulomatous amebic encephalitis in a patient treated with chemotherapy: a case report and literature review
Marcos R. FLORES ; Miranda G. MONTION ; Aneesha N. USMAN ; Munachiso A. NGENE ; Samir RUXMOHAN
Journal of Neurocritical Care 2024;17(2):88-93
Background:
Granulomatous amebic encephalitis (GAE) is caused by Acanthamoeba species or Balamuthia mandrillaris, which are microscopic, free-living amoebas found worldwide. People with compromised immune systems are at an increased risk of fatal cerebral infection caused by Acanthamoeba species, whereas B. mandrillaris can affect both immunocompromised and immunocompetent patients. Infections can involve the central nervous system causing GAE.Case Report: A 71-year-old Caucasian woman, previously diagnosed with chronic lymphocytic leukemia and undergoing chemotherapy, arrived at the emergency department exhibiting seizure-like symptoms. Brain imaging revealed bilateral cerebral masses with central necrosis and hemorrhage, among other findings. The patient underwent a biopsy and was diagnosed with GAE.
Conclusion
Unfortunately, even with the correct diagnosis, GAE leads to rapid deterioration and a higher risk of mortality. This case demonstrates the rapid and severe nature of GAE and emphasizes the need for ongoing studies and better treatment options to improve GAE outcomes.
3.Granulomatous amebic encephalitis in a patient treated with chemotherapy: a case report and literature review
Marcos R. FLORES ; Miranda G. MONTION ; Aneesha N. USMAN ; Munachiso A. NGENE ; Samir RUXMOHAN
Journal of Neurocritical Care 2024;17(2):88-93
Background:
Granulomatous amebic encephalitis (GAE) is caused by Acanthamoeba species or Balamuthia mandrillaris, which are microscopic, free-living amoebas found worldwide. People with compromised immune systems are at an increased risk of fatal cerebral infection caused by Acanthamoeba species, whereas B. mandrillaris can affect both immunocompromised and immunocompetent patients. Infections can involve the central nervous system causing GAE.Case Report: A 71-year-old Caucasian woman, previously diagnosed with chronic lymphocytic leukemia and undergoing chemotherapy, arrived at the emergency department exhibiting seizure-like symptoms. Brain imaging revealed bilateral cerebral masses with central necrosis and hemorrhage, among other findings. The patient underwent a biopsy and was diagnosed with GAE.
Conclusion
Unfortunately, even with the correct diagnosis, GAE leads to rapid deterioration and a higher risk of mortality. This case demonstrates the rapid and severe nature of GAE and emphasizes the need for ongoing studies and better treatment options to improve GAE outcomes.
4.Granulomatous amebic encephalitis in a patient treated with chemotherapy: a case report and literature review
Marcos R. FLORES ; Miranda G. MONTION ; Aneesha N. USMAN ; Munachiso A. NGENE ; Samir RUXMOHAN
Journal of Neurocritical Care 2024;17(2):88-93
Background:
Granulomatous amebic encephalitis (GAE) is caused by Acanthamoeba species or Balamuthia mandrillaris, which are microscopic, free-living amoebas found worldwide. People with compromised immune systems are at an increased risk of fatal cerebral infection caused by Acanthamoeba species, whereas B. mandrillaris can affect both immunocompromised and immunocompetent patients. Infections can involve the central nervous system causing GAE.Case Report: A 71-year-old Caucasian woman, previously diagnosed with chronic lymphocytic leukemia and undergoing chemotherapy, arrived at the emergency department exhibiting seizure-like symptoms. Brain imaging revealed bilateral cerebral masses with central necrosis and hemorrhage, among other findings. The patient underwent a biopsy and was diagnosed with GAE.
Conclusion
Unfortunately, even with the correct diagnosis, GAE leads to rapid deterioration and a higher risk of mortality. This case demonstrates the rapid and severe nature of GAE and emphasizes the need for ongoing studies and better treatment options to improve GAE outcomes.